The past decade has witnessed path-breaking advances with regard to novel therapeutic approaches of thalassaemia and, most significantly, phenomenal developments made in the direction of gene therapy of β- thalassaemia major.
The Mumbai Hematology Group, India, invites healthcare professionals with a special interest in thalassaemia and haemoglobin disorders to a webinar entitled ‘Thalassemia Advances in 2021’, which will take place on Sunday, July 11, at 11.30 am (IST).
The Keynote Speaker of the webinar to provide an overview of the novel therapeutic approaches on thalassaemia and discuss the possible future directions these achievements are likely to take, will be the internationally renowned thalassaemia expert, Dr. M.D. Cappellini, Professor of Internal Medicine, Department of Clinical Sciences and Community, University of Milan, Italy and TIF’s Scientific Advisor.
The President of the Mumbai Hematology Group and Haematologist, Dr. M.B. Agarwal, MD, will moderate the event and discussions among participants.
If you have any queries, please write to Mr. Kalpesh Pambhar (E-mail: email@example.com)